期刊文献+

开博通介入肾显像对肾动脉再血管化治疗疗效的预测价值 被引量:3

Predictive Value of Captopril Renography for Renal Artery Revascularization
下载PDF
导出
摘要 目的 :评价开博通介入肾显像对肾动脉再血管化治疗疗效的预测价值。方法 :3 1例患者经肾动脉造影证实有肾动脉狭窄并行肾动脉再血管化治疗 ,并在行肾动脉再血管化治疗前行基础肾显像 +开博通肾显像。全部患者术后随访时间为 2~ 2 4( 12 5± 9 4)个月。结果 :各种指标对再血管化治疗患者的疗效预测价值不同。从准确性方面看 :开博通肾显像对再血管化治疗疗效的预测准确性为 87 0 % ,高于其他几种指标的预测准确性。阳性预测值为 89 0 % ,高于其他几种指标的预测值。阴性预测值为 83 3 %。结论 Objective: To evaluate the predictive value of captopril renography for the renal artery revascularization.Methods: Renoangiography and revascularization of renal artery were performed in 31 patients with renal artery stenosis from January 1993 to December 2001.Basal renography and captopril renography were performed before renal artery revascularization.A follow up of 2 24 months (average 12 5±9 4 months)was carried out.Results: The predictive values of various indexes for revascularization were different.The predictive accuracy was 87 0%,apparently higher than those of other markers.The positive predictive value was 89 0%,and negative predictive value was 83 3%.Conclusion: The captopril renography has an important predictive value for renal artery revascularization.
出处 《中国循环杂志》 CSCD 北大核心 2003年第1期46-48,共3页 Chinese Circulation Journal
关键词 开博通 肾动脉 再血管化治疗 肾显像 预测价值 介入治疗 肾血管性高血压 Captopril Renography Revascularization Predictive value
  • 相关文献

参考文献5

  • 1[1]Dean RH, Tribble RW, Hansen K J, et al. Evolution of renal insufficiency in ischemic nephropathy. Ann Surg, 1991,213: 446-456.
  • 2[2]Helin KH, Lepantalo M, Edgren J, et al. Predicting the outeome of invasive treatment of renal artery disease. J Intern Med,2000,247L: 105 110.
  • 3[3]Blaufox MD. Should the role of captopril renography extend to the evaluation of chronic renal disease? J Nucl Med, 1994,35: 254-256.
  • 4梁宏,李沂,胡平,等.巯甲丙脯酸99mTc-DTPA肾显像诊断肾血管性高血压的初步临床观察[J].中华核医学杂志,1992,(12):47-49.
  • 5[5]Davidson RA, Barri Y, Wilcox CX. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidn Dis, 1996, 28: 334-338.

同被引文献35

  • 1刘莉,王梅.卡托普利肾动态显像诊断肾血管性高血压的应用研究[J].中国综合临床,2005,21(11):994-997. 被引量:5
  • 2Vesna DG, Stephe, n CT. Renovascular hypertension and ischemic nephropathy. Circulation ,2005,112:1362-1374.
  • 3Taylor A Nally J, Aurell M ,et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. J Nucl Med, 1996, 37 : 1876-1882.
  • 4Ugur O, Peksoy I, Caner B, et al. Renovascular hypertension due to Takayasu's arteritis demonstrated by Tc-99m ethylenedicysteine captopril scintigraphy. Clin Nucl Med, 1996,21:714-716.
  • 5Taylor A. Renovascular hypertension: nuclear medicine techniques. Q J Nucl Med,2002,46:268-282.
  • 6Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: A systematic review. Ann Intern Med,2006,145:901-912.
  • 7Blaufox MD,Fine EJ,Heller S,et al. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. J Nucl Med, 1998,39:522-528.
  • 8Dondi M, Monetti N, Fanti S, et al. Use of technetium-99m-MAG3 for renal scintigraphy after angiotensin-converting enzyme inhibition. J Nucl Med, 1991,32:424-428.
  • 9Blaufox MD, Dubovsky EV, Hilson AJ, et al. Report of the working party group on determining the radionuclide of choice. Am J Hypertens, 1991,4:747 -748.
  • 10Taylor AT Jr, Fletcher JW, Nally JV Jr, et al. Procedure guideline for diagnosis of renovascular hypertension. J Nucl Med, 1998,39: 1297-1302.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部